Eric DeJesus to Present at ARCS Forward: Reducing the Impact of Cancer

Eric DeJesus, PhD, scientist, entrepreneur, and Founder & CEO of Annate Bitherapeutics, will present at ARCS Forward on June 10, 2025 in a live Zoom session titled “Reducing the Impact of Cancer.” He’ll explore how his team is harnessing a novel component of the innate immune system to selectively target and kill cancer cells — with programs aimed at multiple myeloma and pancreatic cancer.

ARCS Forward events are designed as personal, intimate dialogues between ARCS members, scholars, and leading STEM experts. Dr. DeJesus’s participation underscores the translational promise of his work and the broader mission of turning research into treatments.

To learn more about the event or view recordings, visit the ARCS Forward page and browse the playlist on the ARCS Foundation YouTube channel.

• Event details: ARCS Forward — “Reducing the Impact of Cancer”
• ARCS Foundation YouTube channel: ARCS Forward playlist (available there)

Sources: Event listing from ARCS Forward (June 10, 2025) :contentReference[oaicite:1]{index=1}